Drug profile · INN
vortioxetine
BRINTELLIX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
vortioxetine (BRINTELLIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN vortioxetine
Brand BRINTELLIX
Route ORAL
Formulation TABLET:FILM COATED
ATC code N06AX26
Frequently asked questions
What is vortioxetine?
vortioxetine (BRINTELLIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vortioxetine?
BRINTELLIX is a marketed brand name for vortioxetine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vortioxetine?
vortioxetine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.